SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: conor00 who wrote (1166)12/21/1999 4:43:00 PM
From: Tagore  Read Replies (2) | Respond to of 1972
 
Does anyone have any other information about possible HGSI deal? This could send our stock to the moon if real! By the way, the company announced that the safety review board passed Allovectin which means the two pivotal trials are going forward. Actually, this is terrific news since we at least know the trials are going ok.



To: conor00 who wrote (1166)12/22/1999
From: billkirn  Read Replies (2) | Respond to of 1972
 
I called Vical a number of months ago and told them that HGSI was using direct DNA injection to transport one of their candidates. They said, other companies are doing the same thing, and they could not chase all of them. I suspect Vical will eventually reap huge benefits if these candidates make it through trials. Bill


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News